The influence of temperature on antiproliferative effects, cellular uptake and DNA platination of the clinically employed Pt(II)-drugs

Journal of Inorganic Biochemistry

Volumn 102, Issue 4, 2008, Pages 629-635

  Gabano, Elisabetta ^a   Colangelo, Donato ^a   Ghezzi, Anna Rita ^a   Osella, Domenico ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

Cisplatin like complexes; Hyperthermia; ICP MS; Platinum uptake

Indexed keywords

CARBOPLATIN; CISPLATIN; OXALIPLATIN; PLATINUM COMPLEX;

ARTICLE; ATOMIC EMISSION SPECTROMETRY; CELL PROLIFERATION; CELL STRAIN MCF 7; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DNA SYNTHESIS; DRUG EFFECT; DRUG STRUCTURE; HUMAN; HUMAN CELL; HYPERTHERMIA; IC 50; RNA SYNTHESIS; TEMPERATURE SENSITIVITY;

CELL LINE, TUMOR; CELL PROLIFERATION; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MASS SPECTROMETRY; PLATINUM COMPOUNDS; TEMPERATURE;

EID: 40649107392     PISSN: 01620134     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinorgbio.2007.10.006     Document Type: Article

References (64)

1. In: Lippert B. (Ed). Cisplatin. Chemistry and Biochemistry of a Leading Anticancer drug (1999), Wiley VCH, New York
2. Kelland L.R., Abel G., McKeage M.J., Jones M., Goddard P.M., Valenti M., Murrer B.A., and Harrap K.R. Cancer Res. 53 (1993) 2581-2586
3. Jakupec M.A., Galanski M., and Keppler B.K. Rev. Physiol. Biochem. Pharmacol. 146 (2003) 1-53
4. M. Galanski, Recent Patents on Anti-Cancer Drug Discovery, vol. 1, 2006, pp. 285-295.
5. I. Kostova, Recent Patents on Anti-Cancer Drug Discovery, vol. 1, 2006, pp. 1-22.
6. Eckhardt S. Curr. Med. Chem. Anticancer Agents 2 (2002) 419-439
7. Wong E., and Giandomenico C.M. Chem. Rev. 99 (1999) 2451-2466
8. Lebwohl D., and Canetta R. Eur. J. Cancer 34 (1998) 1522-1534
9. Hambley T.W. Coord. Chem. Rev. 166 (1997) 181-223
10. Murry D.J. Pharmacotherapy 17 (1997) 140S-145S
11. Veal G.J., Errington J., Tilby M.J., Pearson A.D., Foot A.B., McDowell H., Ellershaw C., Pizer B., Nowell G.M., Pearson D.G., Boddy A.V., and UKCCSG Pharmacology Working Group. Brit. J. Cancer. 96 (2007) 725-731
12. Raymond E., Faivre S., Woynarowski J.M., and Chaney S.G. Semin. Oncol. 25 (1998) 4-12
13. Galanski M., Jakupec M.A., and Keppler B.K. Curr. Med. Chem. 12 (2005) 2075-2094
14. Najajreh Y., Khazanov E., Jawbry S., Ardeli-Tzaraf Y., Perez J.M., Kasparkova J., Brabec V., Barenholz Y., and Gibson D. J. Med. Chem. 49 (2006) 4665-4673
15. Malinge J.M., Giraud-Panis M.J., and Leng M. J. Inorg. Biochem. 77 (1999) 23-29
16. Kartalou M., and Essigmann J.M. Mutat. Res. 478 (2001) 23-43
17. Desoize B., and Madoulet C. Crit. Rev. Oncol. Hematol. 42 (2002) 317-325
18. Wang K., Lu J., and Li R. Coord. Chem. Rev. 151 (1996) 53-88
19. Ghezzi A.R., Aceto M., Cassino C., Gabano E., and Osella D. J. Inorg. Biochem. 98 (2004) 73-78
20. Miyahara T., Ueda K., Akaboshi M., Shimada Y., Imamura M., and Utsumi H. Jpn. J. Cancer Res. 84 (1993) 336-340
21. Kusumoto T., Holden S.A., Ara G., and Teicher B.A. Int. J. Hyperther. 11 (1995) 575-586
22. Ohno S., Siddik Z.H., Kido Y., Zwelling L.A., and Bull J.M. Cancer Chemother. Pharmacol. 34 (1994) 302-306
23. Takahashi I., Emi Y., Hasuda S., Kakeji Y., Maehara Y., and Sugimachi K. Surgery 131 (2002) 78-84
24. Storm F.K. Radiol. Clin. North Am. 27 (1989) 621-627
25. Herman T.S., Teicher B.A., Chan V., Collins L.S., and Abrams M.J. Int. J. Radiat. Oncol. Biol. Phys. 16 (1989) 443-449
26. Ohtsubo T., Saito H., Tanaka N., Noda I., Saito T., and Kano E. Anticancer Res. 16 (1996) 297-300
27. Ohtsubo T., Igawa H., Saito T., Matsumoto H., Park H., Song C.W., Kano E., and Saito H. Radiat. Res. 156 (2001) 103-109
28. Rietbroek R.C., van de Vaart P.J., Haveman J., Blommaert F.A., Geerdink A., Bakker P.J., and Veenhof C.H. J. Cancer Res. Clin. Oncol. 123 (1997) 6-12
29. Nakao K., Otsuki Y., Akao Y., Ito Y., Marukawa O., Tachibana S., Kawakami M., and Sasaki S. Med. Electron. Microsc. 33 (2000) 44-50
30. Xu M.J., and Alberts D.S. Cancer Chemother. Pharmacol. 21 (1988) 191-196
31. Cohen J.D., Robins H.I., and Schmitt C.L. Cancer Lett. 44 (1989) 205-210
32. Ohtsubo T., Saito H., Tanaka N., Tsuzuki H., Saito T., and Kano E. Chemotherapy 43 (1997) 3-50
33. Eichholtz-Wirth H., and Hietel B. Int. J. Hyperther. 6 (1990) 47-55
34. Wan S.L., Zhang J., Yang D.S., and Fan S.W. Zhejiang Da Xue Xue Bao Yi Xue Ban (J. Zhejiang University. Medical Sciences) 32 (2003) 427-432
35. Beketic-Oreskovic L., Jaksic M., Oreskovic S., and Osmak M. Int. J. Hyperther. 13 (1997) 205-214
36. Mauz-Korholz C., Dietzsch S., Schippel P., Banning U., and Korholz D. Anticancer Res. 23 (2003) 2643-2647
37. Los G., van Vugt M.J., den Engelse L., and Pinedo H.M. Biochem. Pharmacol. 46 (1993) 1229-1237
38. Mosmann T. J. Immunol. Meth. 65 (1983) 55-63
39. Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Gartner F.H., Provengano M.D., Fujimoto E.K., Goeke N.M., Olson B.J., and Klenk D.C. Anal. Biochem. 150 (1985) 76-85
40. Maniatis T., Fritsch E.F., and Sambrook J. Molecular Cloning. A Laboratory Manual (1982), Cold Spring Harbor Laboratory, Cold Spring Harbor, New York
41. Mishima M., Samimi G., Kondo A., Lin X., and Howell S.B. Eur. J. Cancer 38 (2002) 1405-1412
42. Pendyala L., Kidani Y., Perez R., Wilkes J., Bernacki R.J., and Creaven P.J. Cancer Lett. 97 (1995) 177-184
43. Servidei T., Ferlini C., Riccardi A., Meco D., Scambia G., Segni G., Manzotti C., and Riccardi R. Eur. J. Cancer 37 (2001) 930-938
44. Sharp S.Y., O'Neill C.F., Rogers P., Boxall F.E., and Kelland L.R. Eur. J. Cancer 38 (2002) 2309-2315
45. Johnson S.W., Shen D., Pastan I., Gottesman M.M., and Hamilton T.C. Exp. Cell Res. 226 (1996) 133-139
46. Coluccia M., Nassi A., Boccarelli A., Giordano D., Cardellicchio N., Locker D., Leng M., Sivo M., Intini F.P., and Natile G. J. Inorg. Biochem. 77 (1999) 31-35
47. Loh S.Y., Mistry P., Kelland L.R., Abel G., and Harrap K.R. Brit. J. Cancer 66 (1992) 1109-1115
48. Mann S.C., Andrews P.A., and Howell S.B. Cancer Chemother. Pharmacol. 25 (1990) 236-240
49. Gabano E., Ravera M., Colangelo D., and Osella D. Curr. Chem. Biol. 1 (2007) 278-289
50. Beketic-Oreskovic L., Jaksic M., Oreskovic S., and Osmak M. Int. J. Hyperther. 13 (1997) 205-214
51. Dynlacht J.R., and Fox M.H. Radiat. Res. 130 (1992) 48-54
52. Dynlacht J.R., and Fox M.H. Radiat. Res. 130 (1992) 55-60
53. Ohtsubo T., Saito H., Tanaka N., Matsumoto H., Sugimoto C., Saito T., Hayashi S., and Kano E. Cancer Lett. 119 (1997) 47-52
54. Gately D.P., and Howell S.B. Brit. J. Cancer 67 (1993) 1171-1176
55. Ishida S., Lee J., Thiele D.J., and Herskowitz I. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 14298-14302
56. Katano K., Kondo A., Safaei R., Holzer A., Samimi G., Mishima M., Kuo Y.M., Rochdi M., and Howell S.B. Cancer Res. 62 (2002) 6559-6565
57. Safaei R. Cancer Lett. 234 (2006) 34-39
58. Safaei R., and Howell S.B. Crit. Rev. Oncol. Hemat. 53 (2005) 13-23
59. Lin X., Okuda T., Holzer A., and Howell S.B. Mol. Pharmacol. 62 (2002) 1154-1159
60. Holzer A.K., Manorek G.H., and Howell S.B. Mol. Pharmacol. 70 (2006) 1390-1394
61. Beretta G.L., Gatti L., Tinelli S., Corna E., Colangelo D., Zumino F., and Perego P. Biochem. Pharmcol. 68 (2004) 283-291
62. Gelasco A., and Lippard S.J. In: Clarke M.J., and Sadler P.J. (Eds). Metallopharmaceuticals I (1999), Springer Verlag, Berlin Heidelberg 1-43
63. Blommaert F.A., van Dijk-Knijnenburg H.C., Dijt F.J., den Engelse L., Baan R.A., Berends F., and Fichtinger-Schepman A.M. Biochemistry 34 (1995) 8474-8480
64. Platts J.A., Hibbs D.E., Hambley T.W., and Hall M.D. J. Med. Chem. 44 (2001) 472-474